Viewing Study NCT06315153



Ignite Creation Date: 2024-05-06 @ 8:16 PM
Last Modification Date: 2024-10-26 @ 3:24 PM
Study NCT ID: NCT06315153
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-03-18
First Post: 2024-03-11

Brief Title: Comprehensive Assessment of Atherosclerotic Ischemic Stroke Risk and Development of a Prediction Model
Sponsor: Xuanwu Hospital Beijing
Organization: Xuanwu Hospital Beijing

Study Overview

Official Title: Research of Comprehensive Assessment of Carotid Plaque Vulnerability and Development of Atherosclerotic Ischemic Stroke Risk Prediction Model
Status: ACTIVE_NOT_RECRUITING
Status Verified Date: 2023-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: CAIS-pre
Brief Summary: This observational study was designed for the assessment of plaque vulnerability in patients with carotid atherosclerotic stenosis and the development of predictive models for the occurrence and recurrence of atherosclerotic ischemic stroke

The objectives of the study were as follows first to integrate the degree of carotid stenosis and plaque characteristics assessed by vascular ultrasound for a comprehensive assessment of plaque vulnerability second to develop an assessment tool for the risk of future ischemic stroke in patients with asymptomatic carotid stenosis by combining vascular risk factors serologic markers carotid ultrasound characteristics and contrast-enhanced ultrasonographic parameters and third to incorporate vascular ultrasound parameters into existing predictive models of ischemic stroke recurrence risk to develop a risk assessment tool for atherosclerotic ischemic stroke

The main questions it aims to answer are

How to screen high-risk patients and those eligible for revascularization from asymptomatic carotid stenosis patients for primary prevention of stroke
How to improve the prediction accuracy of atherosclerotic ischemic stroke based on existing prediction models for secondary prevention of stroke
Detailed Description: The data from January 2022 to December 2022 was obtained from the electronic medical record system but there will be a two-year follow-up of the data Therefore this is a two-way cohort study containing both a retrospective and prospective cohort

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None